These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27699271)

  • 1. TGF-
    Courau T; Nehar-Belaid D; Florez L; Levacher B; Vazquez T; Brimaud F; Bellier B; Klatzmann D
    JCI Insight; 2016 Jun; 1(9):e85974. PubMed ID: 27699271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice.
    Liu B; Zhang H; Li J; Lu C; Chen G; Zhang G; Lu A; He X
    Planta Med; 2013 Oct; 79(15):1401-7. PubMed ID: 23975869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.
    Llopiz D; Dotor J; Casares N; Bezunartea J; Díaz-Valdés N; Ruiz M; Aranda F; Berraondo P; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
    Int J Cancer; 2009 Dec; 125(11):2614-23. PubMed ID: 19530254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
    Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
    J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.
    Jiang J; Zhang Y; Peng K; Wang Q; Hong X; Li H; Fan G; Zhang Z; Gong T; Sun X
    Acta Biomater; 2017 Oct; 61():114-123. PubMed ID: 28483693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD103 is a hallmark of tumor-infiltrating regulatory T cells.
    Anz D; Mueller W; Golic M; Kunz WG; Rapp M; Koelzer VH; Ellermeier J; Ellwart JW; Schnurr M; Bourquin C; Endres S
    Int J Cancer; 2011 Nov; 129(10):2417-26. PubMed ID: 21207371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Six1,TGF-β,VEGF-C that promoting tumor lymphangiogenesis in human laryngeal carcinoma xenografts in nude mice].
    Wang L; Zhu MS; Tian JH; Xue HT; Liu HL; Zhang JH
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 30(24):1960-1964. PubMed ID: 29798275
    [No Abstract]   [Full Text] [Related]  

  • 14. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions.
    Wada J; Suzuki H; Fuchino R; Yamasaki A; Nagai S; Yanai K; Koga K; Nakamura M; Tanaka M; Morisaki T; Katano M
    Anticancer Res; 2009 Mar; 29(3):881-8. PubMed ID: 19414323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression.
    Takahashi N; Rieneck K; van der Kraan PM; van Beuningen HM; Vitters EL; Bendtzen K; van den Berg WB
    Osteoarthritis Cartilage; 2005 May; 13(5):426-38. PubMed ID: 15882566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.